PANCREATIC INTRADUCTAL PAPILLARY-MUCINOUS NEOPLASM

Clinical trials for PANCREATIC INTRADUCTAL PAPILLARY-MUCINOUS NEOPLASM explained in plain language.

Never miss a new study

Get alerted when new PANCREATIC INTRADUCTAL PAPILLARY-MUCINOUS NEOPLASM trials appear

Sign up with your email to follow new studies for PANCREATIC INTRADUCTAL PAPILLARY-MUCINOUS NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

Major trial seeks better Post-Surgery defense against pancreatic cancer

Disease control Completed

This large, completed study tested whether adding a targeted drug (erlotinib) to standard chemotherapy, or adding radiation therapy after chemotherapy, could help patients live longer after surgery for pancreatic cancer. It involved 546 adults whose pancreatic tumors were surgica…

Matched conditions: PANCREATIC INTRADUCTAL PAPILLARY-MUCINOUS NEOPLASM

Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

PANCREATIC INTRADUCTAL PAPILLARY-MUCINOUS NEOPLASM

Get alerted when new PANCREATIC INTRADUCTAL PAPILLARY-MUCINOUS NEOPLASM trials appear

Major trial seeks better Post-Surgery defense against pancreatic cancer